ResMed's average Accounts Receivable for the
three
months ended in Dec. 2023 was $711 Mil. ResMed's Revenue for the
three
months ended in Dec. 2023 was $1,163 Mil.
Hence, ResMed's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 55.80.
The historical rank and industry rank for ResMed's Days Sales Outstanding or its related term are showing as below:
RMD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 55.35 Med: 71.86 Max: 79.57
Current: 56.49
During the past 13 years, ResMed's highest Days Sales Outstanding was 79.57. The lowest was 55.35. And the median was 71.86.
RMD's Days Sales Outstanding is ranked better than 59.95% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 63.91
vs RMD: 56.49
ResMed's Days Sales Outstanding
declined
from Dec. 2022 (57.06) to Dec. 2023 (55.80).
ResMed Days Sales Outstanding Historical Data
The historical data trend for ResMed's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed Days Sales Outstanding Distribution
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where ResMed's Days Sales Outstanding falls into.
ResMed Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed (NYSE:RMD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
ResMed Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of ResMed's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RMD has been successfully added to your 